AIDS Treatment News logo      

November 29, 2010

Gilead asks FDA to approve new HIV drug combo - BusinessWeek

BusinessWeek: [Nov. 23] "Drugmaker Gilead Sciences Inc. said Tuesday it asked the Food and Drug Administration to approve a single pill combination of its HIV treatment Truvada and Tibotec Pharmaceuticals' rilpivirine.

"The companies have been working together to develop the combination since July of 2009."